Galectin Therapeutics, Inc. (GALT)
3.43
-0.06
(-1.86%)
USD |
NASDAQ |
Oct 20, 16:00
3.43
0.00 (0.00%)
After-Hours: 20:00
Galectin Therapeutics Gross Profit (TTM) : -0.057M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.057M |
| March 31, 2026 | -0.055M |
| December 31, 2025 | -0.053M |
| September 30, 2025 | -0.022M |
| June 30, 2025 | -0.031M |
| March 31, 2025 | -0.038M |
| December 31, 2024 | -0.037M |
| September 30, 2024 | -0.036M |
| June 30, 2024 | -0.035M |
| March 31, 2024 | -0.026M |
| December 31, 2023 | -0.049M |
| September 30, 2023 | -0.048M |
| June 30, 2023 | -0.04M |
| March 31, 2023 | -0.047M |
| December 31, 2022 | -0.025M |
| September 30, 2022 | -0.028M |
| June 30, 2022 | -0.038M |
| March 31, 2022 | -0.041M |
| December 31, 2021 | -0.041M |
| September 30, 2021 | -0.039M |
| June 30, 2021 | -0.039M |
| March 31, 2021 | -0.037M |
| December 31, 2020 | -0.036M |
| September 30, 2020 | -0.036M |
| June 30, 2020 | -0.034M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.034M |
| December 31, 2019 | -0.025M |
| September 30, 2019 | -0.016M |
| June 30, 2019 | -0.008M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | -0.001M |
| September 30, 2017 | -0.003M |
| June 30, 2017 | -0.005M |
| March 31, 2017 | -0.007M |
| December 31, 2016 | -0.007M |
| September 30, 2016 | -0.006M |
| June 30, 2016 | -0.006M |
| March 31, 2016 | -0.006M |
| December 31, 2015 | -0.007M |
| September 30, 2015 | -0.008M |
| June 30, 2015 | -0.009M |
| March 31, 2015 | -0.01M |
| December 31, 2014 | -0.01M |
| September 30, 2014 | -0.011M |
| June 30, 2014 | -0.011M |
| March 31, 2014 | -0.011M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Mirum Pharmaceuticals, Inc. | 504.67M |
| ACADIA Pharmaceuticals, Inc. | 1.038B |
| Alnylam Pharmaceuticals, Inc. | 3.827B |
| Anika Therapeutics, Inc. | 75.00M |
| Savara, Inc. | -0.281M |